BIOMAT Database Logo BIOMAT Database Logo

DISTRIBUTION AND METABOLIC FATE OF ANGIOTENSIN II AND VARIOUS DERIVATIVES. 1964

F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008660 Metabolism The chemical reactions in living organisms by which energy is provided for vital processes and activities and new material is assimilated. Anabolism,Catabolism,Metabolic Concepts,Metabolic Phenomena,Metabolic Processes,Metabolic Phenomenon,Metabolic Process,Metabolism Concepts,Metabolism Phenomena,Process, Metabolic,Processes, Metabolic,Concept, Metabolic,Concept, Metabolism,Concepts, Metabolic,Concepts, Metabolism,Metabolic Concept,Metabolism Concept,Phenomena, Metabolic,Phenomena, Metabolism,Phenomenon, Metabolic
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000809 Angiotensins Oligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized. Angiotensin

Related Publications

F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
Studies on the fate of naproxen. II. Metabolic fate in various animals and man.
November 1978, Chemical & pharmaceutical bulletin,
F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
Absorption, distribution and metabolic fate of psychotropic drugs.
January 1970, Psychopharmacology bulletin,
F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
The enzymatic degradation of various angiotensin II derivatives by serum, plasma or kidney homogenate.
July 1963, Biochemical pharmacology,
F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
Metabolic fate of histidylleucine, a metabolite of angiotensin I.
May 1968, The Journal of clinical endocrinology and metabolism,
F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
[Clinical application of angiotensin II derivatives].
January 1976, Nihon rinsho. Japanese journal of clinical medicine,
F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
[Clinical application of angiotensin II derivatives].
August 1978, Horumon to rinsho. Clinical endocrinology,
F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
Studies on tumor necrosis factor (TNF): II. Metabolic fate and distribution of human recombinant TNF.
January 1987, Lymphokine research,
F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
Distribution and behavior of isoselenouronium salts in the body. V. Acute toxicity and metabolic fate of selenium derivatives.
January 1976, Strahlentherapie,
F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
Excretion, distribution and metabolic fate of 3H-alpha-chaconine.
February 1976, Research communications in chemical pathology and pharmacology,
F M BUMPUS, and R R SMEBY, and I H PAGE, and P A KHAIRALLAH
[Research on the metabolic fate & mechanism of antituberculous activity of derivatives of isonicotinic acid hydrazide. I. Metabolic fate of derivatives of isoniazid].
September 1957, Kekkaku : [Tuberculosis],
Copied contents to your clipboard!